Pharmascience, Inc.
22Patents
13Active
22Granted
44Portfolio score
Filing activity: Jan 9, 1998 → Sep 12, 2016 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6211247A | Administration of resveratrol to prevent or treat restenosis following coronary intervention | Human Necessities | 146 | Expired |
| US6414037B1 | Pharmaceutical formulations of resveratrol and methods of use thereof | Performing Operations; Transporting | 132 | Expired |
| US6008260A | Cancer chemopreventative composition and method | Performing Operations; Transporting | 84 | Expired |
| US6022901A | Administration of resveratrol to prevent or treat restenosis following coronary intervention | Human Necessities | 51 | Expired |
| US6287600A | Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin | Human Necessities | 48 | Expired |
| US6183779A | Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin | Human Necessities | 45 | Expired |
| US6582688B1 | Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds, and therapeutic, cosmetical or food use of said compounds | Chemistry; Metallurgy | 26 | Expired |
| US6455028B1 | Ipratropium formulation for pulmonary inhalation | Human Necessities | 23 | Expired |
| US8012944B2 | Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent | Chemistry; Metallurgy | 11 | Expired |
| US8063095B2 | IAP BIR domain binding compounds | Human Necessities | 4 | Active |
| US9447102B2 | Protein kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US8575113B2 | BIR domain binding compounds | Chemistry; Metallurgy | 1 | Active |
| US8163792B2 | IAP BIR domain binding compounds | Physics | 1 | Active |
| US9796716B2 | Selective inhibitors of Tec and Src protein kinase families | Chemistry; Metallurgy | 0 | Active |
| US9795608B2 | Protein kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9624239B2 | Protein kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9284318B2 | Protein kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9284350B2 | IAP BIR domain binding compounds | Human Necessities | 0 | Active |
| US8765681B2 | IAP BIR domain binding compounds | Chemistry; Metallurgy | 0 | Active |
| US8648094B2 | IAP BIR domain binding compounds | Physics | 0 | Active |
| US9365614B2 | IAP BIR domain binding compounds | Chemistry; Metallurgy | 0 | Active |
| US9822120B2 | Protein kinase inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.